This financial relationship between NIH experts and Gilead is especially concerning in light of revelations that NIH has a financial stake in the Bill Gates-funded Moderna vaccine, another competitor to Hydroxychloroquine. Chloroquine critic Dr. Anthony Fauci's NIAID, which funded the Bat Coronavirus research at the Wuhan Institute of Virology believed to be the source of the outbreak, is part of NIH.

HERE IS THE FINANCIAL DISCLOSURE LIST FOR THE NIH EXPERT CORONAVIRUS TREATMENT PANEL. The experts with disclosed ties to Gilead include consultants, people who provided Gilead research support, and honoraria. Members of the panel also disclosed ties to Merck and INOVIO Pharmaceuticals, which took $9 million from a Gates-backed company to develop a Coronavirus vaccine.

Gilead is driving up their prices from what was previously expected (as the company has done in the past).